Brenton K. Ahrens - 25 Jun 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Brenton K. Ahrens
Issuer symbol
ITRM
Transactions as of
25 Jun 2022
Net transactions value
$0
Form type
4
Filing time
28 Jun 2022, 21:00:36 UTC
Previous filing
17 Jun 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +113,276 $0.000000 113,276 25 Jun 2022 Ordinary Shares 113,276 $0.2000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on April 1, 2023